Attached Carole Ho - 23 Aug 2022 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
Chief Medical Officer
Signature
/s/ Tyler Nielsen, by power of attorney
Issuer symbol
DNLI
Transactions as of
23 Aug 2022
Net transactions value
-$77,520
Form type
4
Filing time
25 Aug 2022, 18:10:33 UTC
Previous filing
23 Aug 2022
Next filing
02 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Sale $77,520 -2,424 -1.4% $31.98 170,663 23 Aug 2022 See footnote F1, F2
holding DNLI Common Stock 25,000 23 Aug 2022 See footnote F3
holding DNLI Common Stock 105,597 23 Aug 2022 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.
F2 The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.
F3 The shares are held of record by the Rohatgi-Ho Irrevocable GST Trust for the benefit of the Reporting Person's children.
F4 Includes 105,187 restricted stock units.